199 related articles for article (PubMed ID: 34492818)
1. lncRNA TUG1 as a ceRNA promotes PM exposure-induced airway hyper-reactivity.
Li B; Huang N; Wei S; Xv J; Meng Q; Aschner M; Li X; Chen R
J Hazard Mater; 2021 Aug; 416():125878. PubMed ID: 34492818
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA taurine up regulated 1 promotes osteosarcoma cell proliferation and invasion through upregulating Ezrin expression as a competing endogenous RNA of micro RNA-377-3p.
Yao Q; Li Y; Pei Y; Xie B
Bioengineered; 2022 Jan; 13(1):1767-1778. PubMed ID: 35012433
[TBL] [Abstract][Full Text] [Related]
3. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA TUG1 promotes proliferation and inhibits apoptosis in multiple myeloma by inhibiting miR-29b-3p.
Liu D; Wang J; Liu M
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842339
[No Abstract] [Full Text] [Related]
8. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis.
Su Q; Liu Y; Lv XW; Dai RX; Yang XH; Kong BH
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H332-H344. PubMed ID: 31858814
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
Xie CH; Cao YM; Huang Y; Shi QW; Guo JH; Fan ZW; Li JG; Chen BW; Wu BY
Tumour Biol; 2016 Nov; 37(11):15031-15041. PubMed ID: 27658774
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TUG1 functions as a ceRNA for miR-1-3p to promote cell proliferation in hepatic carcinogenesis.
Tang K; Lv D; Miao L; Mao Y; Yu X
J Clin Lab Anal; 2022 May; 36(5):e24415. PubMed ID: 35421276
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA TUG1 Attenuates Insulin Resistance in Mice with Gestational Diabetes Mellitus via Regulation of the MicroRNA-328-3p/SREBP-2/ERK Axis.
Tang X; Qin Q; Xu W; Zhang X
Diabetes Metab J; 2023 Mar; 47(2):267-286. PubMed ID: 36653891
[TBL] [Abstract][Full Text] [Related]
13. LncRNA TUG1 regulates the balance of HuR and miR-29b-3p and inhibits intestinal epithelial cell apoptosis in a mouse model of ulcerative colitis.
Tian Y; Wang Y; Li F; Yang J; Xu Y; Ouyang M
Hum Cell; 2021 Jan; 34(1):37-48. PubMed ID: 33047284
[TBL] [Abstract][Full Text] [Related]
14. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
[TBL] [Abstract][Full Text] [Related]
15. Silencing of the lncRNA
Zhang B; Zhao C; Hou L; Wu Y
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
[TBL] [Abstract][Full Text] [Related]
16. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
Tang Y; Yang P; Zhu Y; Su Y
Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
[TBL] [Abstract][Full Text] [Related]
19.
Zhai K; Liu B; Gao L
Hum Gene Ther; 2020 Dec; 31(23-24):1274-1287. PubMed ID: 32808542
[No Abstract] [Full Text] [Related]
20. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis.
Zhang B; Sun YF; Zhang XM; Jiang N; Chen Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4940-4953. PubMed ID: 32432757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
